Clinical Trials Browser

Phase EARLY_PHASE1 × Bortezomib × Lymphoid × Clear all

NCT01171092 2017-01-11

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

Phase EARLY_PHASE1 Completed

LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

NCT00515138 2012-04-12

A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant

Phase EARLY_PHASE1 Terminated

Lymphoma, B-Cell